The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic value of CA 19-9 and carcinoembrionic antigen (CEA) in duodenal adenocarcinoma (DA): An institutional retrospective cohort study.
 
Ellery Altshuler
No Relationships to Disclose
 
William King
No Relationships to Disclose
 
Raymond Richhart
No Relationships to Disclose
 
Keegan Hones
No Relationships to Disclose
 
Akash Mathavan
No Relationships to Disclose
 
Akshay Mathavan
No Relationships to Disclose
 
Daniel F. Leach
No Relationships to Disclose
 
Yasmeen Murtaza
No Relationships to Disclose
 
Jimmy Lee
No Relationships to Disclose
 
Denise Manfrini
No Relationships to Disclose
 
Mohit Mathavan
No Relationships to Disclose
 
Zahara Chowdhury
No Relationships to Disclose
 
Sherise C. Rogers
No Relationships to Disclose
 
Ibrahim Nassour
No Relationships to Disclose
 
Brian Hemendra Ramnaraign
Consulting or Advisory Role - Ipsen
 
Ilyas Sahin
No Relationships to Disclose
 
Aaron J Franke
No Relationships to Disclose
 
Thomas J. George
Consulting or Advisory Role - Pfizer; Tempus
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); OncoC4 (Inst); Seagen (Inst)
 
Steven J. Hughes
No Relationships to Disclose
 
Jesus C. Fabregas
No Relationships to Disclose